Vaishali Pharma Limited — Others, 16-11-2024: Copy of Newspaper Publication

Vaishali Pharma Limited has announced a board meeting on November 14, 2024, where the Board approved the un-audited financial results for the second quarter and half-year ended September 30, 2024. Key figures include total income from operations of ₹9,860.15 crore and a net profit after tax of ₹12.97 crore for the half-year period. This update reflects the company's ongoing efforts to enhance its financial position and operational efficiency. Investors may view this as a positive outlook, indicating potential for stability and growth moving forward.